China continues to distribute the $125 billion of government funds that have been allocated for improving China’s healthcare. The priorities for this year will be improving public hospitals and providing better preparation to general practitioners, and healthcare improvements in the countryside. Public... Read More
On December 27, 2010, China’s State Food and Drug Administration (SFDA) website was updated with an announcement on 96 new industry standards that will affect medical devices in China. 34 of these new industry standards are mandatory (labeled YY) while the remaining... Read More
On December 21, 2010, representatives from Taiwan and China met to sign a new agreement that supports the bio-technology industries of both territories. Two important outcomes of this agreement include upcoming cooperation on clinical trial standards and vaccine development. With clinical trial... Read More
The hospital industry in China is growing at an extraordinary rate. Thirty percent of the country's 2009 healthcare reform initiatives are earmarked for building new health facilities. In other words, since 2009, the Chinese government has been injecting $37 billion into the... Read More
In early November, the Chinese State Food and Drug Association (SFDA) initiated a joint inspection for drug safety by six government departments. After releasing the Notice on Distributing Special Action Plan for Cracking Down on Violations of Intellectual Property Rights and the... Read More
China's economic growth has skyrocketed during the last 15 years. In the second quarter of 2010, China's nominal gross domestic product (GDP) of $1.33 trillion surpassed that of Japan, $1.29 trillion. Along with the economic surge, China's healthcare market also is growing.... Read More
The SFDA issued “Requirements on Application Dossiers in Common Technical Document (CTD) Format for Pharmaceutical Products” in late September 2010. The release of this CDT format for Pharmaceutical Registration Applications continues China’s trend of integrating with international regulatory standards. Through further integration,... Read More
Since 2007, the United States Food and Drug Administration (FDA) has been working more closely with China’s primary medical regulatory authority, the State Food and Drug Administration (SFDA) to increase regulatory control of imported and exported medical goods. Regulatory harmonization deals such... Read More
The global recession has left medical companies scrambling to find new markets. China's GDP, adjusted for purchasing power parity, is currently second in the world and has surpassed Japan's. Medical companies should focus on this growing market. However, before entering the Chinese... Read More
Asia's cases of diabetes are at an all-time high. The International Diabetes Federation (IDF) estimates that more than 125 million people in Asia are suffering from the condition this year. These numbers are climbing quickly. There likely will be more than 200... Read More